ATOSSA THERAPEUTICS, INC. (ATOS) has 19 open-market insider trades by 7 insiders since 2013. The most active filer is H. Lawrence Remmel, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Gregory L. Weaver | Dir | — | 4 | $1.3M | 2023-11-15 |
| Jonathan Finn | Dir | — | 1 | $44K | 2026-05-12 |
| Steven C. Quay | CEOPres | — | 4 | $33K | 2026-03-27 |
| H. Lawrence Remmel | Dir | — | 5 | $33K | 2026-05-12 |
| Shu-Chih Chen | Dir | — | 3 | $24K | 2026-05-12 |
| Kyle Guse | CFOSecretary | — | 1 | $3K | 2018-05-30 |
| Alexander D. Cross | Dir | — | 1 | $3K | 2013-05-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Steven C. Quay | President | Buy | $10K | 2025-05-21 |
| H. Lawrence Remmel | Director | Buy | $7K | 2025-03-26 |
| Jonathan Finn | Director | Buy | $44K | 2024-04-10 |
| Gregory L. Weaver | CFO & Director +1 | Sell | $33K | 2023-11-15 |
| Gregory L. Weaver | EVP & CFO | Buy | $49K | 2023-06-20 |
| Gregory L. Weaver | Director | Sell | $1.2M | 2021-07-02 |
Companies that share insiders with ATOS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Kyle Guse | CFO & Secretary | Buy | $3K | 2017-11-15 |
| H. Lawrence Remmel | Director | Buy | $2K | 2017-04-17 |
| H. Lawrence Remmel | Director | Buy | $495 | 2016-04-01 |
| Shu-Chih Chen | Director & 10% | Buy | $6K | 2016-03-09 |
| Steven C. Quay | President & 10% | Buy | $8K | 2016-02-16 |
| Steven C. Quay | President & 10% | Buy | $10K | 2016-01-19 |
| H. Lawrence Remmel | Director | Buy | $7K | 2015-06-12 |
| Gregory L. Weaver | Director | Buy | $26K | 2013-11-21 |
| Steven C. Quay | CEO & 10% | Sell | $41K | 2013-10-01 |